Metformin Dosage Guide: Starting Dose, Max Dose, Titration (2026)

Metformin Dosage Guide: Starting Dose, Maximum Dose, and How to Titrate

Metformin dosing is not one-size-fits-all. Starting at the right dose and titrating slowly is the key to minimizing GI side effects. Here is a complete dosage reference for type 2 diabetes and other uses.

By James Okafor, RPh, MBA

Medically reviewed by Dr. Rafael Morales, PharmD, BCACP, CDE

Published June 21, 2026

Last reviewed June 15, 2026

2 min read

Why Metformin Dosing Matters

Metformin is highly effective for [type 2 diabetes](/conditions/type-2-diabetes), but GI side effects (nausea, diarrhea, stomach upset) are the most common reason patients stop taking it. The key to minimizing these side effects is starting at a low dose and titrating slowly — not jumping straight to the maximum dose. Taking [metformin](/drugs/metformin) with food also significantly reduces GI side effects.

Standard Dosing for Type 2 Diabetes

Formulation	Starting Dose	Titration	Target Dose	Maximum Dose
Immediate-release (IR)	500 mg once or twice daily with meals	Increase by 500 mg/week as tolerated	1,000–1,500 mg twice daily	2,550 mg/day
Extended-release (ER/XR)	500–1,000 mg once daily with evening meal	Increase by 500 mg/week as tolerated	1,500–2,000 mg once daily	2,000–2,500 mg/day

Recommended Titration Schedule (Immediate-Release)

Week 1: 500 mg once daily with dinner
Week 2: 500 mg twice daily (with breakfast and dinner)
Week 3: 500 mg with breakfast + 1,000 mg with dinner
Week 4+: 1,000 mg twice daily (target dose for most patients)

Extended-Release vs Immediate-Release

Extended-release metformin (Glucophage XR, Fortamet, Glumetza) has the same efficacy as immediate-release but causes significantly fewer GI side effects. It is taken once daily with the evening meal. For patients who cannot tolerate immediate-release metformin due to GI side effects, switching to the extended-release formulation often resolves the problem.

Renal Dosing: When to Reduce or Stop

Metformin is renally eliminated and can accumulate in patients with kidney disease, increasing the risk of lactic acidosis. Current FDA guidance:

eGFR (mL/min/1.73m²)	Recommendation
≥45	No dose adjustment; continue metformin
30–44	Continue with caution; monitor renal function every 3–6 months; do not start new patients
<30	Contraindicated — stop metformin

Metformin for Prediabetes (Off-Label)

The Diabetes Prevention Program (DPP) trial showed that metformin 850 mg twice daily reduced the risk of progression from prediabetes to type 2 diabetes by 31% (vs. 58% with intensive lifestyle intervention). The ADA recommends considering metformin for prediabetes in patients with BMI ≥35, age <60, or prior gestational diabetes.

Metformin for PCOS (Off-Label)

For polycystic ovary syndrome, typical doses are 500 mg 2–3 times daily or 1,500–2,000 mg/day of extended-release. The goal is to improve insulin sensitivity, restore menstrual regularity, and reduce androgen levels.

Important Dosing Notes

Always take metformin with food to minimize GI side effects
Hold metformin for 48 hours before and after contrast dye procedures (CT scans with IV contrast)
Hold metformin if you develop acute illness with dehydration, vomiting, or diarrhea
Check renal function (eGFR) at least annually; more frequently if CKD is present
Supplement with vitamin B12 if taking metformin long-term (metformin reduces B12 absorption)

References

Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (DPP). N Engl J Med. 2002;346(6):393-403.
American Diabetes Association. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1):S158-S178.